GOLDMAN SACHS GROUP INC

Holdings History for RHYTHM PHARMACEUTICALS, INC. - COM (RYTM)

Symbol: RYTM on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM
Latest Disclosed Ownership: 1.82M shares
Security Ownership: 3%

Shares, Excluding Options vs Price

Value, Excluding Options

THE GOLDMAN SACHS GROUP, INC. ownership in RHYTHM PHARMACEUTICALS, INC. COM (RYTM)

2025-02-10 - THE GOLDMAN SACHS GROUP, INC. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.82M shares of RHYTHM PHARMACEUTICALS, INC. COM (RYTM). This represents 3% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
THE GOLDMAN SACHS GROUP, INC.	3%		$96.3M	1.82M			$52.97	13G/A	12/31/2024	10 Feb 2025 17:30:28

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	0.02%	-0.02%	$101M	1.81M	-2,067,590	-53.3%	$55.98	Q4 2024
9/30/2024	0.04%	-0.01%	$203M	3.88M	-1,408,839	-26.6%	$52.39	Q3 2024
6/30/2024	0.04%	+0%	$217M	5.29M	+177,034	+3.46%	$41.06	Q2 2024
3/31/2024	0.05%	+0%	$221M	5.11M	+63,667	+1.26%	$43.33	Q1 2024
12/31/2023	0.05%	0%	$232M	5.05M	-112,607	-2.18%	$45.97	Q4 2023
9/30/2023	0.03%	0%	$118M	5.16M	-25,472	-0.49%	$22.93	Q3 2023
6/30/2023	0.02%	0%	$85.5M	5.19M	-124,690	-2.35%	$16.49	Q2 2023
3/31/2023	0.03%	+0%	$94.7M	5.31M	+108,911	+2.09%	$17.84	Q1 2023
12/31/2022	0.04%	+0%	$151M	5.2M	+424,614	+8.89%	$29.12	Q4 2022
9/30/2022	0.03%	+0.01%	$117M	4.78M	+1,616,792	+51.2%	$24.50	Q3 2022
6/30/2022	0%	0%	$13.1M	3.16M	-179,364	-5.37%	$4.15	Q2 2022
3/31/2022	0.01%	+0%	$38.5M	3.34M	+243,202	+7.85%	$11.52	Q1 2022
12/31/2021	0.01%	+0%	$30.9M	3.1M	+191,229	+6.58%	$9.98	Q4 2021
9/30/2021	0.01%	+0.01%	$37.9M	2.91M	+1,837,108	+172%	$13.06	Q3 2021
6/30/2021	0.01%	+0%	$20.9M	1.07M	+409,057	+62.1%	$19.58	Q2 2021
3/31/2021	0%	+0%	$14M	659K	+606,742	+1158%	$21.27	Q1 2021
12/31/2020	0%	0%	$1.56M	52.4K	-3,856	-6.85%	$29.73	Q4 2020
9/30/2020	0%	+0%	$1.22M	56.3K	+23,195	+70.1%	$21.66	Q3 2020
6/30/2020	0%	0%	$738K	33.1K	-18,841	-36.3%	$22.31	Q2 2020
3/31/2020	0%	0%	$790K	51.9K	-12,927	-19.9%	$15.22	Q1 2020
12/31/2019	0%	+0%	$1.49M	64.8K	+12,949	+25%	$22.96	Q4 2019
9/30/2019	0%	0%	$1.12M	51.9K	-3,952	-7.08%	$21.58	Q3 2019
6/30/2019	0%	+0%	$1.23M	55.8K	+8,878	+18.9%	$22.01	Q2 2019
3/31/2019	0%	+0%	$1.29M	47K	+26,935	+134%	$27.40	Q1 2019
12/31/2018	0%	+0%	$538K	20K	+9,561	+91.3%	$26.86	Q4 2018
9/30/2018	0%	+0%	$305K	10.5K	+2,952	+39.3%	$29.13	Q3 2018
6/30/2018	0%	+0%	$235K	7.52K	+7,518	NEW	$31.26	Q2 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.